VNDA240719C9000
- 0.05
- 0.000.00%
Vanda Pharmaceuticals Newsroom
Vanda Pharmaceuticals Initiated at Overweight by Cantor Fitzgerald
Vanda Pharmaceuticals Initiated at Overweight by Cantor
Vanda Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/11/2024 105.61% Cantor Fitzgerald → $11 Initiates Coverage On → Overweight 02/25/2022 124.3%
Cantor Fitzgerald Initiates Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $11
Cantor Fitzgerald analyst Charles Duncan initiates coverage on $Vanda Pharmaceuticals(VNDA.US)$ with a buy rating, and sets the target price at $11.According to TipRanks data, the analyst has a
Vanda Will Request Relief From Court That Includes Order Requiring Defendants to Discontinue Marketing Generic Versions of HETLIOZ >VNDA
Vanda Will Request Relief From Court That Includes Order Requiring Defendants to Discontinue Marketing Generic Versions of HETLIOZ >VNDA
Vanda Intends to Proceed With Discovery in the Case to Continue Pursuing Its Claims >VNDA
Vanda Intends to Proceed With Discovery in the Case to Continue Pursuing Its Claims >VNDA
Vanda: Court Concluded Issues of Patentability Weren't Same as Those Resolved in Prior Patent-Infringement Litigation Between Parties >VNDA
Vanda: Court Concluded Issues of Patentability Weren't Same as Those Resolved in Prior Patent-Infringement Litigation Between Parties >VNDA
Vanda: Court Denied Motions for Judgment on Pleadings That Were Filed by Teva Pharmaceuticals USA and Apotex >VNDA
Vanda: Court Denied Motions for Judgment on Pleadings That Were Filed by Teva Pharmaceuticals USA and Apotex >VNDA
What's Going On With Vanda Pharmaceuticals Shares Today?
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company."Consistent with the position indicated in its June 13, 2024 letter to
Express News | Vanda Pharmaceuticals Inc. Shares Are Trading Lower After Future Pak Withdrew Its Proposal to Purchase the Company
Express News | Future Pak Late Wednesday Announced The Withdrawal Of Its Proposal To Purchase Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Drops After Future Pak Walks Away
Express News | Future Pak Withdraws Proposal to Purchase Vanda Pharmaceuticals Inc.
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with Avegant to develop optimized waveguide optical modules for
Express News | Vanda Pharmaceuticals Shares Are Trading Lower After the Company's Board Determined That Recent Takeover Proposals Were Not in Its Best Interests
Vanda Shares Fall Premarket After Company Rejects Takeover Bids
By Colin Kellaher Shares of Vanda Pharmaceuticals moved lower in premarket trading Thursday after the pharmaceutical company said it has rejected a pair of takeover proposals as inadequate. Vanda la
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday.Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) fell sharply in today's pre-market trading
Express News | Shares of Vanda Pharmaceuticals Down 6% Premarket as Co Rejects Future Pak and Cycle Pharma's Takeover Offers
Reported Wednesday, Vanda Pharmaceuticals Rejects Unsolicited Takeover Bids, Citing Undervaluation
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the Company's Board of Directors (the "Board"), following careful review and consultation with its independent financial and legal
Express News | Vanda Pharmaceuticals Inc - Proposal From Cycle Group and Revised Proposal From Future Pak Undervalue Vanda
Express News | Vanda Pharmaceuticals Inc - Board Has Rejected Proposals